Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ECYT

Endocyte (ECYT) Stock Price, News & Analysis

Endocyte logo

About Endocyte Stock (NASDAQ:ECYT)

Advanced Chart

Key Stats

Today's Range
$23.99
$23.99
50-Day Range
N/A
52-Week Range
$2.81
$24.00
Volume
N/A
Average Volume
2.12 million shs
Market Capitalization
$1.97 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ECYT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Endocyte and its competitors with MarketBeat's FREE daily newsletter.

ECYT Stock News Headlines

Telix Pharmaceuticals Ltd (TLX)
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
See More Headlines

ECYT Stock Analysis - Frequently Asked Questions

Endocyte, Inc. (NASDAQ:ECYT) released its earnings results on Wednesday, November, 7th. The biopharmaceutical company reported ($0.17) EPS for the quarter, missing the consensus estimate of ($0.16) by $0.01. The biopharmaceutical company earned $0.09 million during the quarter, compared to analysts' expectations of $0.02 million. Endocyte had a negative trailing twelve-month return on equity of 21.19% and a negative net margin of 32,296.09%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Endocyte investors own include Bristol Myers Squibb (BMY), Meta Platforms (META), Gilead Sciences (GILD), Advanced Micro Devices (AMD), Micron Technology (MU), Netflix (NFLX) and NVIDIA (NVDA).

Company Calendar

Last Earnings
11/07/2018
Today
7/07/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:ECYT
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$55.06 million
Net Margins
-32,296.09%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$70 thousand
Price / Sales
28,133.42
Price / Cash Flow
N/A
Book Value
$1.99 per share
Price / Book
12.06

Miscellaneous

Free Float
N/A
Market Cap
$1.97 billion
Optionable
Optionable
Beta
-0.01
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (NASDAQ:ECYT) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners